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Background: Migrants account for the majority of 
tuberculosis (TB) cases in low-incidence countries in 
western Europe. TB incidence among migrants might 
be influenced by patterns of migration, but this is not 
well understood. Aim: To investigate differences in TB 
risk across migrant groups according to migrant status 
and region of origin. Methods: This prospective cohort 
study included migrants ≥ 18 years of age who obtained 
residency in Denmark between 1 January 1993 and 31 
December 2015, matched 1:6 to Danish-born individu-
als. Migrants were grouped according to legal sta-
tus of residency and region of origin. Incidence rates 
(IR) and incidence rate ratios (IRR) were estimated 
by Poisson regression. Results: The cohort included 
142,314 migrants. Migrants had significantly higher 
TB incidence (IR: 120/100,000 person-years (PY); 95% 
confidence interval (CI): 115–126) than Danish-born 
individuals (IR: 4/100,000 PY; 95% CI: 3–4). The IRR 
was significantly higher in all migrant groups com-
pared with Danish-born (p < 0.01). A particularly higher 
risk was seen among family-reunified to refugees 
(IRR: 61.8; 95% CI: 52.7–72.4), quota refugees (IRR: 
46.0; 95% CI: 36.6–57.6) and former asylum seekers 
(IRR: 45.3; 95% CI: 40.2–51.1), whereas lower risk was 
seen among family-reunified to Danish/Nordic citizens 
(IRR 15.8; 95% CI: 13.6–18.4) and family-reunified to 
immigrants (IRR: 16.9; 95% CI: 13.5–21.3). Discussion: 
All migrants had higher TB risk compared with the 
Danish-born population. While screening programmes 
focus mostly on asylum seekers, other migrant groups 
with high risk of TB are missed. Awareness of TB risk 
in all high-risk groups should be strengthened and 
screening programmes should be optimised.
Introduction
Improving tuberculosis (TB) care among migrants is 
considered a key public health priority towards global 
elimination of TB [1]. Migrants account for the major-
ity of TB in low-incidence countries, defined as those 
with a notification rate < 10 per 100,000 population per 
year [1] and comprise over 70% of TB cases in countries 
like Denmark (incidence: 5/100,000 population/year) 
and the United Kingdom (UK) (incidence: 9/100,000 
population/year) [2,3]. While TB rates in native-born 
European populations are decreasing, the proportion 
of cases occurring in migrants is increasing, which may 
be partly attributed to the recent surge of refugees in 
some European countries [4]. In this paper, migrants 
refer to all groups of foreign-born individuals.
Migrants from high-incidence TB countries, defined as 
notification rate > 20/100,000 population/year [5], are 
likely to be at increased risk of TB several years follow-
ing migration because of an increased risk of reactiva-
tion of latent TB (LTBI) [6-9]. Some migrants may also 
be vulnerable to TB because of risk factors associated 
with migration [10]. Refugees in particular are poten-
tially exposed to poor and dangerous travel conditions, 
overcrowded housing and poor access to healthcare 
during flight [11]. After arrival in the host country, 
potential barriers such as language, lack of knowledge 
regarding the healthcare system and patient rights, and 
lack of entitlement can present challenges to accessing 
the healthcare system [12].
Across Europe, different strategies for TB screening 
among migrants have been implemented to improve TB 
detection and treatment, and to reduce the burden of 
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TB in low-incidence countries with programmes focus-
ing on active TB screening before and at arrival [13]. In 
Denmark, a voluntary medical assessment is provided 
for asylum seekers when they arrive at the national 
reception centre. Since 2002, national guidelines have 
recommended screening for TB among asylum seekers 
from high-incidence countries, but formalised, system-
atic screening was not effectuated before 2017 [14]. 
There is no systematic health or TB screening among 
quota refugees or family-reunified migrants [15].
A better understanding of the patterns of TB risk among 
migrants is needed to tailor health services according 
to needs and to optimise policies for migrants’ con-
tact with healthcare systems. The majority of previous 
studies have focused on region of origin as a risk fac-
tor, but recently there has been a focus on migrant sta-
tus as such [16]. Migrant status is of interest because 
exposure to TB risk factors and access to TB screening 
differs. Only a few studies have assessed TB incidence 
among subgroups of migrants and how different types 
of migration affects the risk of TB [9,17].
To investigate differences in risk of TB across migrant 
groups, we compared TB incidence according to migrant 
status and region of origin with a Danish-born popula-
tion in a large-scale cohort study among migrants in 
Denmark spanning 23 years.
Methods
Design and study population
This register-based, prospective cohort study used 
data obtained from the Danish Immigration Service 
and from Statistics Denmark. All migrants ≥ 18 years 
of age who obtained residency in Denmark between 
1 January 1993 and 31 December 2015 were included. 
The age cut-off was used because this is the cut-off 
between being a child or an adult in Denmark at arrival 
following the United Nations (UN) Convention on the 
Rights of the Child [18].
Individuals were included from the date of receiving 
residency. Date of residency was used for this study 
because it is an official registered date available for 
all migrants in Denmark while registered dates of 
entry are much more uncertain and not available for all 
migrants. A Danish-born comparison group was iden-
tified through Statistics Denmark and matched 1:6 on 
age and sex based on the first day of the year when the 
migrant-match was granted residency. Migrants with 
a diagnosis of TB before the date of residency were 
excluded for further analysis. The construction of the 
cohort has previously been described in more detail 
including the matching procedure and exclusion pro-
cess because of missing values [19,20].
A TB case was defined as active TB, including both pul-
monary and extrapulmonary TB.
Table 1
Migration status terminology used in cohort study of tuberculosis, Denmark, 1993–2015
Term Definition
Migranta [4,40]
Person who is moving or has moved across an international border away from his/her habitual place of 
residency regardless of his/her legal status, whether the movement was voluntary or involuntary, the 
cause of movement, and the length of stay outside the country of origin.
-Refugee [4,40]
Person who because of a well-founded fear of persecution for reasons of race, religion, nationality, 
social group or politics, war or violence has been forced to flee his or her country and seeks protection in 
another country. Status as refugee is obtained when asylum is granted. A refugee can be either a former 
asylum seeker or a quota refugee.
--Asylum seeker [4,40] Person who seeks safety from persecution or serious harm in a country other than his/her own country and awaits a decision on the application for refugee status in the receiving country.
--Quota refugee [41] 
 
--(Resettlement refugee)
Person who is transferred from one country to another country that has agreed to resettle him/her and 
ultimately grant him/her permanent settlement as refugee at arrival following an agreement with the 
United Nations High Commissioner for Refugees or a similar organisation.
-Immigrant [41] Person who has been granted residency through family reunification or employment purpose.
--Family-reunified to Danish/
Nordic citizen [41]
Person who has been granted residency and resettlement with a Danish/Nordic citizen spouse or partner 
who resides in the country of immigration.
--Family-reunified to immigrant 
[41]
Person who has been granted residency and resettlement with a spouse or partner who has been granted 
permanent residence in the country of immigration, likely through employment or education.
--Family-reunified to refugee 
[41]
Person who has been granted residency and resettlement with a spouse or partner who holds refugee 
status in the country of immigration.
--Labour migrantb [40] Person who has been granted residency through employment purpose.
-Undocumented migrantb [4] Person who does not have the necessary documentation to enter or remain legally in a country
a Migrants refer to the whole group. Subgroups are defined underneath.
b Labour migrants and undocumented migrants are not included in the current study.
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Migrants were grouped into five groups based on the 
legal basis of their residence: (i) former asylum seek-
ers, (ii) quota refugees, (iii) family-reunified to Danish/
Nordic citizens, (iv) family-reunified to immigrants, 
and (v) family-reunified to refugees (Table 1). Migrants 
were grouped into six groups according to region of 
origin, with these regions being modified versions of 
those used by the World Bank Group [21]: (i) Eastern 
Europe and Central Asia; (ii) Europe, North America 
and Oceania; (iii) Middle East and North Africa; (iv) 
Latin America and the Caribbean; (v) South Asia, East 
Asia and Pacific, hereafter referred to as South-East 
Asia; and (vi) sub-Saharan Africa (countries repre-
sented in the cohort are listed in Supplementary Table 
S1).
Data generation
All Danish-born individuals are assigned a unique 
10-digit central person registration (CPR) number at 
birth whereas migrants receive a CPR number at date of 
residency. The CPR number can be used to track indi-
viduals through public registries at an individual level. 
Migrant status and country of origin were obtained 
from the Danish Immigration Service. Data on age, 
sex, immigration and emigration were obtained from 
Statistics Denmark. Data on TB cases were obtained via 
cross- linkage of CPR numbers through the International 
Reference Laboratory of Mycobacteriology (IRLM) and 
the National Surveillance Register (NSR), Department 
of Infectious Disease Epidemiology and Prevention 
(DIDE) both at Statens Serum Institut, Copenhagen. 
In Denmark, all TB diagnostics are centralised at IRLM 
and nationwide data on culture-verified TB cases were 
retrieved from here. TB is a notifiable disease by law 
and the treating physician submits a notification to the 
NSR, DIDE. We retrieved data on all notified TB cases 
from the NSR, DIDE to ensure the inclusion of culture-
negative cases, i.e. patients with clinical or paraclinical 
findings suggestive of TB and prompting TB treatment. 
Since HIV is a known risk factor for TB [22], we retrieved 
HIV diagnoses from the NSR, DIDE in order to charac-
terise risk-profile of the cohort.
Data analysis
Descriptive analyses were carried out using chi-squared 
and t-test analyses. Poisson regression analysis was 
used to calculate incidence rates (IR) and incidence 
rate ratios (IRR) of TB with 95% confidence intervals 
(CI) and using the logarithm of follow-up time as offset. 
Follow-up time was calculated as time from inclusion 
until: (i) TB diagnosis, (ii) emigration, (iii) death or (iv) 
study end whichever came first and was used to quan-
tify the number of years a person was at risk of TB.
First, we calculated IRR for TB adjusted for age and sex, 
and stratified for migrant status and region of origin 
using Danish-born as the reference group. We identi-
fied interactions between sex and migrant status, and 
between sex and region of origin. We present data as 
overall for migrants compared with the Danish-born 
Figure 
Flow chart of the selection process of the final study cohort, including migrants and Danish-born, Denmark, 1993–2015
142,505 newly arrived migrants ≥ 18 years of age
• 59,893 refugees
• 82,612 family-reunified immigrants
Cross-linked by central person registration number with registries at:
• International Reference Laboratory of Mycobacteriology, 
   Statens Serum Institut
• Department of Infectious Disease Epidemiology and Prevention,
    Statens Serum Institut
142,314 newly-arrived migrants
• 59,752 refugees
• 82,562 family-reunified immigrants
854,820 Danish-born controls
n = 997,134
TB before residency/inclusion excluded:
• 191 migrants (141 former asylum seekers, 37 family reunified
to Danish/Nordic citizens, 7 family-reunified
to immigrants, 6 family-reunified to refugees)
• 210 Danish-born individuals 
Matched 1:6 on age and sex with Danish-born individuals
(n = 855,030)
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population. In order to determine the potential influ-
ence of migrant status, we calculated IRR for TB among 
migrants in a model adjusted for age, sex and region of 
origin, and stratified for migrant status and region of 
origin using asylum seekers as the reference group. We 
included age as a time-varying covariate and adjusted 
for age in 10-year intervals.
All analyses were performed in SAS version 9.4 (SAS 
Institute, Cary, United States (US)).
We reported our study results according to the STROBE 
guidelines [23].
Ethical approval
This study was approved by the Danish Data Protection 
Agency (Number 2016–41–4576). No further ethical 
approval is required in Denmark for registry-based 
research. Data were analysed anonymously via online 
access to Statistics Denmark’s database.
Results
In total, 142,314 migrants were included in the cohort 
(Figure). Of these, 40.9% were family-reunified to 
Danish/Nordic citizens, 37.9% were former asylum 
seekers and 10.3% were family-reunified to refugees 
(Table 2). A total of 854,820 Danish-born individuals 
made up the control cohort. The distribution of region 
of origin differed. The Middle East and North Africa 
were the most common region of origin for family-
reunified to refugees (42.9%), former asylum seekers 
(37.6%) and quota refugees (35.9%) whereas Eastern 
Europe and Central Asia was the most common for 
family-reunified to immigrants (55.9%) and South-
East Asia for family-reunified to Danish/Nordic citizens 
(33.1%) (p < 0.01). Among migrants, 56.1% were female 
and the proportion of females was higher among fam-
ily-reunified to refugees (80.8%), family-reunified to 
Danish/Nordic citizens (68.3%) and family-reunified 
to immigrants (64.2%) in contrast to quota refugees 
(40.5%) and former asylum seekers (36.4%) (p < 0.01).
We found 1,841 TB cases among migrants and 398 
among the Danish-born population. Characteristics 
are presented in  Table 3. The distribution of region of 
origin differed among groups with most former asy-
lum seekers (71.4%) and family-reunified to refugees 
(75.4%) being from sub-Saharan Africa, whereas most 
quota refugees (51.2%), family-reunified to Danish/
Nordic citizens (66.1%), and family-reunified to immi-
grants (44.6%) were from South-East Asia (p < 0.01) 
(Table 3). Among migrants, 53.3% of TB cases were 
female (p < 0.01), whereas 39.2% of TB cases among 
the Danish-born population were female (p < 0.01). 
Among migrant groups, the proportion of females was 
higher among family-reunified to refugees (73.2%) and 
family-reunified to Danish/Nordic citizens (71.5%) in 
contrast to among former asylum seekers (42.8%) and 
quota refugees (25.6%) (p < 0.01).
Among TB cases, the prevalence of HIV among migrants 
was 2.3% and among the Danish-born population 2.0% 
(p = 0.72). The highest prevalence of HIV was seen 
among quota refugees (6.4%) and family-reunified to 
Danish/Nordic citizens (6.2%) (p < 0.01).
Overall, the IR of TB among migrants was 120 per 
100,000 person-years of follow-up (PY) (95% CI: 115–
126) compared with the Danish-born population who 
had an IR of 4 per 100,000 PY (95% CI: 3–4) (Table 4). 
The IR was highest among family-reunified to refugees 
(199/100,000 PY; 95% CI: 179–221), quota refugees 
(192/100,000 PY; 95% CI: 161–229) and former asylum 
seekers (156/100,000 PY; 95% CI: 146–167) (p < 0.01). 
According to region of origin, the IR was highest among 
migrants from sub-Saharan Africa (575/100,000 
PY; 95% CI: 541–611) with especially high IR among 
migrants from Somalia (849/100,000 PY; 95% CI: 
794–907). From Somalia, former asylum seekers 
(883/100,000 PY; 95% CI: 816–955) and family-reuni-
fied to refugees (787/100,000 PY; 95% CI: 693–895) 
had the highest IR, whereas family-reunified to Danish/
Nordic citizens had the lowest IR (575/100,000 PY; 95% 
CI: 239–1,382).
Compared with the Danish-born population, the 
adjusted IRR of TB was significantly higher among 
all migrant groups (p < 0.01). Especially high IRR were 
seen among family-reunified to refugees (61.8; 95% CI: 
52.7–72.4), quota refugees (46.0; 95% CI: 36.6–57.6) 
and former asylum seekers (45.3; 95% CI: 40.2–51.1). 
When looking at region of origin, the IRR were signifi-
cantly higher among all regions of origin (p < 0.01), with 
especially high IRR among migrants from sub-Saharan 
Africa (151.2; 95% CI: 134.4–170.2) and South-East 
Asia (41.5; 95% CI: 36.2–47.6).
Table 5  shows IR and IRR of TB among migrants by 
migrant status and region of origin. Overall, family-
reunified to refugees, quota refugees and former 
asylum seekers had the highest IR. After adjusting 
for age, sex and region of origin, the IRR of TB was 
significantly lower for family-reunified to Danish/Nordic 
citizens (0.45; 95% CI: 0.39–0.80) and family-reunified 
to immigrants (0.64; 95% CI: 0.51–0.80) compared 
with former asylum seekers. There was no difference 
between quota refugees, family-reunified to refugees 
and former asylum seekers.
In the stratified analysis for migrant status and region 
of origin, the highest IR was seen for migrants from 
sub-Saharan Africa, particularly among former asy-
lum seekers, family-reunified to refugees and quota 
refugees (p < 0.01) (Table 5). Among migrants from 
sub-Saharan Africa, the adjusted IRR was significantly 
lower for quota refugees (0.45; 95% CI: 0.34–0.61), 
family-reunified to Danish/Nordic citizens (0.22; 95% 
CI: 0.17–0.28) and family-reunified to immigrants 
(0.28; 95% CI: 0.15–0.53) compared with former asy-
lum seekers. There was no difference between former 
asylum seekers and family-reunified to refugees (0.95; 
95% CI: 0.82–1.11).
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Table 2
Baseline characteristics of study cohort by migrant status, Denmark, 1993–2015 (n = 997,134)
Characteristics
Danish-born All migrants Former asylum seekers
Quota 
refugees
Family-reunified to 
Danish/Nordic citizens
Family-reunified 
to immigrants
Family-reunified 
to refugees
% n % n % n % n % n % n % n
Total cohort 85.7 854,820 14.3 142,314 37.9 53,860 4.1 5,892 40.9 58,135 6.9 9,780 10.3 14,647
Age at 
residency 
(migrants) or 
cohort inclusion 
(Danish-born 
population), 
years (mean, 
SD)
32.7 10.7 32.7 10.7 34.3 11.8 33.1 11.1 31.8 9.2 29.1 10.1 32.4 11.0
Sex
Female 56.1 479,189 56.1 79,784 36.4 19,582 40.5 2,384 68.3 39,706 64.2 6,277 80.8 11,835
Male 43.9 375,631 43.9 62,530 63.4 34,278 59.5 3,508 31.7 18,429 35.8 3,503 19.2 2,812
Region of origin
Eastern Europe 
and Central Asia NA NA 24.4 34,755 33.9 18,263 0.7 41 16.8 9,791 55.9 5,471 8.1 1,189
Europe, North 
America and 
Oceania
NA NA 10.8 15,354 0.4 234 0.0 1 24.2 14,066 6.1 599 3.1 454
Latin 
America and the 
Caribbean
NA NA 3.5 4,955 0.1 44 3.0 177 7.9 4,612 0.9 87 0.2 35
Middle 
East and North 
Africa
NA NA 25.1 35,733 37.6 20,263 35.9 2,119 10.3 5,970 11.2 1,099 42.9 6,282
South-East Asia NA NA 22.4 31,911 9.8 5,271 33.8 1,992 33.1 19,238 20.4 1,995 23.3 3,415
Sub-Saharan 
Africa NA NA 13.8 19,606 18.2 9,785 26.5 1,562 7.7 4,458 5.4 529 22.3 3,272
10 most frequent countries of origin
Afghanistan NA NA 4.6 6,487 7.9 4,240 6.7 394 0.4 215 0.5 45 10.9 1,593
Bosnia and 
Herzegovina NA NA 10.5 14,918 25.8 13,879 0.0 0.0 0.7 389 0.8 75 3.9 575
Iran NA NA 3.7 5,235 4.2 2,249 12.3 723 2.1 1,239 0.8 81 6.4 943
Iraq NA NA 8.6 12,166 13.4 7,194 19.8 1,167 1.0 552 0.8 74 21.7 3,179
Philippines NA NA 2.6 3,713 0.0 2 0.0 0 6.1 3,521 1.8 172 0.1 18
Russia NA NA 2.4 3,359 1.6 876 0.3 20 3.9 2,236 1.0 94 0.9 133
Somalia NA NA 6.4 9,144 11.1 5,963 3.8 222 0.3 156 0.5 53 18.9 2,750
Syria NA NA 8.4 11,951 18.6 9,989 3.1 181 0.3 200 0.3 33 10.6 1,548
Thailand NA NA 5.0 7,133 0.0 1 0.0 0 12.0 6,967 1.4 139 0.3 26
Turkey NA NA 6.4 9,087 0.1 58 0.0 2 8.6 4,981 40.3 3,945 0.7 101
HIV positive 0.1 401 0.4 540 0.1 74 1.4 83 0.6 333 0.3 25 0.2 25
Follow-up time, 
years (mean, 
SD)
12.4 7.1 7.3 10.8 11.0 8.0 11.1 6.6 10.0 6.6 13.3 6.8 11.3 6.9
Events follow-up
Tuberculosis 
cases 0.04 398 1.3 1,841 1.7 923 2.1 125 0.6 372 0.9 92 2.3 329
Death 3.6 30,565 2.5 3,559 4.1 2,227 3.0 176 1.3 738 1.9 182 1.6 236
Emigration 0.0 0 14.3 20,365 10.1 5,541 7.6 449 19.3 11,218 11.7 1,147 14.4 2,110
Population at 
study end 96.4 823,857 81.9 116,549 84.1 45,269 87.3 5,142 78.8 45,807 85.5 8,359 81.7 11,972
NA: not applicable; SD: standard deviation.
Data are presented as % (n) unless otherwise stated.
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Discussion
Overall, all migrants in this study experienced signifi-
cantly higher TB incidence compared with Danish-born 
across all migrant statuses and regions of origin. The 
study showed a difference in TB risk across migrant 
groups with higher risk among family-reunified to 
refugees, quota refugees and former asylum seekers, 
whereas family-reunified to Danish/Nordic citizens and 
family-reunified to immigrants had lower risks.
Other studies have also found a high risk of TB among 
migrants [9,17,24-26]. The TB incidence in our migrant 
population was 120 per 100,000 PY (95% CI: 115–126) 
over a mean study period of 10.8 years, and was 30 
times higher than the incidence among the Danish-
born population. This incidence was higher than that 
of a study among migrants in Norway (80/100,000 PY; 
95% CI: 76–84) following migration [26]. One potential 
reason for the difference could be that the Norwegian 
cohort included migrants as young as 5 years of age, 
which could contribute to a lower TB incidence. A study 
among migrants in the UK found a TB incidence of 147 
per 100,000 PY (95% CI: 140–154) following migra-
tion [9], which was higher than the TB incidence in our 
cohort. In the UK study, migrants were predominantly 
from TB high-risk countries, whereas the migrants in 
our study were from both low- and high-risk countries 
(Supplementary Table S1).
Some studies have also included the role of migra-
tion status as TB risk factor. In a study from Canada, 
being a refugee or a family-reunified immigrant was a 
strong predictor of TB following migration compared 
with being a business or labour immigrant [17]. Asylum 
seekers and quota refugees were presented as one 
refugee group. The study from the UK [9] also reported 
that family-reunified immigrants experienced the high-
est TB incidence (320/100,000 PY; 95% CI: 244–419) 
among migrants, which was otherwise comprised of 
resettlements and dependents, students and working 
immigrants. This TB incidence was markedly higher 
than the TB incidence among our family-reunified immi-
grants (91/100,000 PY; 95% CI: 85–97), but the demo-
graphics of family-reunified immigrants in the UK were 
not specified in more detail so we do not know whether 
the two populations were comparable.
The higher proportion of females among migrant TB 
cases than the Danish-born population is likely to 
reflect an overall difference in the distribution of sex 
in the migrant population with more females than 
males resettling in Denmark. The calculated TB risk 
was slightly lower among female than male migrants 
(IRR: 0.82; 95% CI: 0.75–0.90, data not shown), which 
is consistent with what was found in western Sweden 
[27]. When looking at migrant status, the proportions 
differed. Male and female migrants differ in their pat-
terns of migration which reflects in the sex distribu-
tion. Most male migrants arrive as asylum seekers or 
quota refugees, whereas many female migrants arrive 
as either family-reunified to refugees or family-reuni-
fied to Danish/Nordic citizens. Among the Danish-born 
population, TB cases were most often in males, con-
sistent with the general pattern in Denmark, where TB 
among the Danish-born population is associated with 
risk factors such as male sex and social marginalisa-
tion [28].
High rates of TB according to region of origin are well 
known from TB surveillance data in low incidence TB 
countries in western Europe. Migrants from TB endemic 
countries, particularly from countries in sub-Saharan 
Africa and South-East Asia, have consistently been 
shown to have elevated TB rates following migration 
[9,22,29]. In our study, nearly half of migrant TB cases 
were from Somalia and thereby contributed largely to 
the risk of TB. Another important aspect was that TB 
cases among former asylum seekers and family-reuni-
fied to refugees were mainly from sub-Saharan Africa, 
especially Somalia (68.0%), largely driving the risk of 
TB in these migrant groups. Somalia is a high-incidence 
country (IR: 266/100,000 PY [3]) and Somali migrants 
constitute a long-term, high-risk group in Scandinavian 
countries [27,30,31]. However, even though Somalia is 
a high-incidence country, the incidence in our cohort 
among asylum seekers from Somalia was much higher 
than the reported incidence in Somalia. In contrast, 
family-reunified to Danish/Nordic citizens from Somalia 
had lower incidence. This may possibly reflect risk fac-
tors among asylum seekers related to migration such 
as history of imprisonment, overcrowding and precari-
ous living conditions, compared to family-reunified to 
Danish/Nordic citizens who typically travel under less 
strenuous means and arrive directly from their country 
of origin. This association with migrant status among 
refugees from Africa has also been observed else-
where. Asylum seekers from western Africa arriving in 
Italy had a higher yield of TB screening at arrival than 
the incidence in their country of origin [32]. Although, 
one important notion is, that reported TB notifications 
from African countries is likely to be underreported.
Migrants accounted for a larger proportion of HIV than 
the Danish-born population, consistent with epide-
miological HIV patterns in western Europe [33]. Quota 
refugees and family-reunified to Danish/Nordic citizens 
comprised the largest groups of HIV positive migrants 
and the majority came from countries with on-going 
HIV epidemics, such as Congo, Kenya and Thailand 
[34]. Most migrants are infected abroad and unaware 
of their HIV status, and seeking treatment is usu-
ally not the reason for migrating [33]. Interestingly, a 
previous study found that family-reunified to Danish-
Nordic citizens were later presenters of HIV than quota 
refugees [35]. One potential reason may be that quota 
refugees are offered voluntary HIV testing by the 
International Organisation for Migration before arrival 
in Denmark and a potential HIV diagnosis is followed 
up after arrival. Family-reunified immigrants are not 
offered any health assessment upon arrival and the 
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late presentation may be a reflection of differences 
in introduction to the Danish healthcare system, inad-
equate screening practises or different health-seeking 
behaviour [35].
TB screening has been implemented in most European 
countries [13]. Studies show a high risk of TB among 
migrants upon arrival and that patterns of migration 
are indicators of the risk of TB [29,36]. One review 
found a pooled prevalence of TB of 283 per 100,000 
screened (95% CI: 216–349) among migrants at arrival 
[29]. When stratified, the yield among refugees was 
577 per 100,000 screened (95% CI: 206–949), among 
asylum seekers it was 267 per 100,000 screened (95% 
CI: 194–341) and among other immigrants it was 225 
per 100,000 screened (95% CI: 129–322). The other 
immigrant group were pooled from studies including 
students, family-reunified immigrants, labour immi-
grants etc. and therefore did not allow any conclusion 
solely regarding family-reunified immigrants. Another 
review reported a pooled TB prevalence of 300 per 
100,000 screened (95% CI: 224–396) among asylum 
seekers at arrival [36]. The differences in TB at arrival 
may reflect a risk of TB related to migrant status among 
Table 3
Baseline characteristics of tuberculosis casesa in study cohort by migrant status, Denmark, 1993–2015 (n = 2,239)
Characteristics
Danish-born All migrants Former asylum seekers
Quota 
refugees
Family-reunified to 
Danish/Nordic citizens
Family-reunified 
to immigrants
Family-reunified 
to refugees
% n % n % n % n % n % n % n
Age at diagnosis, 
years (mean, SD) 42.1 10.8 36.0 12.2 36.9 13.1 35.9 12.2 34.6 9.1 33.9 11.5 35.8 12.6
Time to diagnosis, 
years (mean, SD) 8.8 5.6 4.3 4.1 4.3 4.2 4.3 3.8 4.6 4.1 4.4 4.2 3.9 3.9
Total TB cases 100 398 100 1,841 100 923 100 125 100 372 100 92 100 329
Sex
Female 39.2 156 53.3 982 42.8 395 25.6 32 71.5 266 52.2 48 73.2 241
Male 60.8 242 46.7 859 57.2 528 74.4 93 28.5 106 47.8 44 26.8 88
Region of origin
East 
Europe and Central 
Asia
NA NA 10.7 197 14.6 135 0.0 0 7.0 26 34.8 32 1.2 4
Europe, North 
America and Oceania NA NA 0.8 15 0.2 2 0.0 0 2.4 9 2.2 2 0.6 2
Middle East and North 
Africa NA NA 5.5 102 5.5 51 10.4 13 3.5 13 7.6 7 5.5 18
Latin America and 
the Caribbean NA NA 0.3 6 0.1 1 0.0 0 1.3 5 0.0 0 0.0 0
South-East Asia NA NA 26.2 483 8.1 75 51.2 64 66.1 246 44.6 41 17.3 57
Sub-Saharan Africa NA NA 56.4 1,038 71.4 659 38.4 48 19.6 73 10.9 10 75.4 248
10 most frequent countries of origin
Afghanistan NA NA 4.7 86 3.1 57 3.2 4 0.3 1 0.0 0 7.3 24
Bosnia and 
Herzegovina NA NA 5.6 104 11.2 103 0.0 0 0.0 0 1.1 1 0.0 0
Iraq NA NA 3.2 58 4.1 38 4.8 6 0.5 2 0.0 0 3.6 12
Myanmar/Burma NA NA 2.2 40 0.2 2 25.6 32 0.0 0 0.0 0 1.8 6
Pakistan NA NA 3.7 69 0.1 1 0.0 0 12.9 48 18.5 17 0.9 3
Philippines NA NA 3.2 59 0.0 0 0.0 0 14.5 54 5.4 5 0.0 0
Somalia NA NA 47.1 873 66.9 617 9.6 12 1.3 5 5.4 5 71.1 234
Thailand NA NA 4.6 85 0.0 0 0.0 0 21.2 79 6.5 6 0.0 0
Turkey NA NA 2.2 40 0.2 2 0.0 0 4.3 16 22.8 21 0.3 1
Vietnam NA NA 2.7 51 0.2 2 1.6 2 7.8 29 4.3 4 4.2 14
HIV positive 2.0 8 2.3 42 0.4 4 6.4 8 6.2 23 4.3 4 0.9 3
Disease siteb
Pulmonary 
tuberculosis 87.4 348 52.4 965 51.6 476 48.8 61 56.5 210 59.8 55 49.5 163
Extrapulmonary 
tuberculosis 10.3 41 46.3 852 47.8 442 42.4 53 42.2 157 40.2 37 49.5 163
NA: not applicable; SD: standard deviation.
a All cases of tuberculosis: all active tuberculosis cases, including both pulmonary and extrapulmonary tuberculosis.
b Site unknown not listed.
Data are presented as n (%) unless otherwise stated.
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others, and support our results of differences in TB 
among migrants following resettlement.
Our study underlines that family-reunified to refugees 
may be a high-risk group of TB compared with other 
family-reunified immigrants and should be prioritised 
in arrival screening. Asylum seekers and quota refugees 
leave their home under critical events and may face 
overcrowded camps or prisons, poor nutrition, stress 
and barriers to healthcare favouring both transmission 
and reactivation of TB [10]. Family-reunified to refugees 
migrate under different legal terms than asylum seek-
ers and quota refugees, but given that many migrate 
under critical events and face refugee camps etc., they 
might still be a highly vulnerable group compared with 
other family-reunified migrants. This means that even 
though they are legally different, the migration pattern 
for family-reunified to refugees is similar to that of asy-
lum seekers. In contrast, family-reunified to Danish/
Nordic citizens and family-reunified to immigrants are 
more likely to travel under less strenuous means and in 
addition, arrive within a stronger support system.
Strengthening TB screening programmes upon arrival 
for high-risk groups might reduce the high rates of 
TB following migration. If migrants are not all equally 
introduced to the healthcare system or systematically 
offered TB screening this may contribute to inequali-
ties among migrants [15]. Among migrants, relevant 
TB screening is accepted and the uptake is high [37]. 
Ensuring TB screening is offered to migrants most at 
risk, i.e. family-reunified to refugees, quota refugees 
and asylum seekers, would increase equity in relation 
Table 4
Incidence rate and incidence rate ratio of tuberculosis casesa among migrants by migrant status and region of origin, 
Denmark, 1993–2015 (n = 997,134)
Characteristics Total (n) TB cases (n) IR per 100,000 PY (95% CI) Crude IRR (95% CI)
Adjusted IRRb (95% 
CI)
Migrant status
Danish-born population 854,820 398 4 (3–4) 1 (ref) 1 (ref)
Migrants 142,314 1,841 120 (115–126) 32.0 (28.7–35.7) 32.4 (29.0–36.1)
Former asylum seekers 53,860 923 156 (146–167) 41.6 (37.0–46.9) 45.3 (40.2–51.1)
Quota refugees 5,892 125 192 (161–229) 51.1 (41.8–62.5) 46.0 (36.6–57.6)
Family-reunified to Danish/Nordic citizen 58,135 372 64 (58–71) 17.1 (14.9–19.7) 15.8 (13.6–18.4)
Family-reunified to immigrant 9,780 92 71 (57–87) 18.8 (15.0–23.6) 16.9 (13.5–21.3)
Family-reunified to refugee 14,647 329 199 (179–221) 53.0 (45.8–61.4) 61.8 (52.7–72.4)
Region of origin
Denmark 854,820 398 4 (3–4) 1 (ref) 1 (ref)
Eastern Europe and Central Asia 34,755 197 40 (35–46) 10.6 (8.9–12.6) 10.5 (8.8–12.5)
Europe, North America and Oceania 15,354 15 9 (6–15) 2.5 (1.5–4.1) 2.7 (1.6–4.5)
Latin America and the Caribbean 4,955 6 14 (6–31) 3.7 (1.6–8.2) 4.1 (1.8–9.1)
Middle East and North Africa 35,733 102 32 (26–38) 8.4 (6.8–10.5) 8.2 (6.5–10.2)
South-East Asia 31,911 483 148 (135–162) 39.4 (34.5–45.0) 41.5 (36.2–47.6)
Sub-Saharan Africa 19,606 1,038 575 (541–611) 153.0 (136.3–171.8) 151.2 (134.4–170.2)
10 most frequent countries of origin among TB cases
Denmark 854,820 398 4 (3–4) 1 (ref) 1 (ref)
Afghanistan 6,487 86 119 (96–147) 31.8 (25.1–40.1) 31.3 (24.7–39.7)
Bosnia and Herzegovina 14,918 104 42 (35–51) 11.3 (9.1–14.0) 11.9 (9.5–14.8)
Iraq 12,166 58 33 (26–43) 8.9 86.8–11.7) 8.9 (6.7–11.9)
Myanmar/Burma 1,188 40 418 (307–570) 111.4 (80.5–154.2) 99.0 (69.5–140.9)
Pakistan 2,942 69 200 (158–253) 53.3 (41.3–68.8) 47.3 (36.5–61.4)
Philippines 3,713 59 193 (150–249) 51.5 (39.2–67.7) 57.1 (35.7–91.3)
Somalia 9,144 873 849 (794–907) 226.0 (200.7–254.4) 222.7 (197.4–251.3)
Thailand 7,133 85 125 (101–154) 33.2 (26.3–42.0) 71.3 (52.6–96.6)
Turkey 9,087 40 34 (25–46) 9.0 (6.5–12.5) 7.5 (5.4–10.5)
Vietnam 2,183 51 195 (148–257) 52.0 (38.9–69.6) 54.8 (39.3–76.2)
CI: confidence interval; IR: incidence rate; IRR: incidence rate ratio; PY: person-years; ref: reference group for comparison; TB: tuberculosis.
a All cases of tuberculosis: all active tuberculosis cases, including both pulmonary and extrapulmonary tuberculosis.
b Adjusted for age and sex.
Bold indicates p < 0.01.
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to host populations in terms of TB prevention and 
access to healthcare [38].
Strengths and limitations
Major strengths of this study were the cohort size and 
the duration of follow-up time. Also, because of the 
unique possibilities of the Danish CPR number, we 
could identify and follow a large cohort of migrants on 
an individual level on a nationwide basis. Further to 
that, TB data were retrieved from IRLM and NSR, DIDE, 
which are believed to cover all TB cases diagnosed 
in Denmark. We therefore believe our data reflect the 
high TB incidence among migrants after settling in a 
low-incidence TB country and the differences across 
groups.
However, there are some limitations to consider. First, 
we only included migrants ≥ 18 years of age so we can-
not make any inference regarding children. At arrival in 
Denmark, adults and children were received differently 
at arrival in terms of health assessment and provision 
of social support during the study period, so only adults 
were included to minimise potential bias. Second, 
undocumented migrants were not represented in the 
study cohort and these individuals may be at high TB 
risk and experience significant barriers to healthcare. 
Third, some migrants may have had TB before arrival 
and before receiving residency. Because valid informa-
tion on date of arrival in Denmark was not available for 
all migrants, we included participants based on date 
of residency, which is when a CPR number that allows 
for the exact follow-up through registries is assigned. 
A consequence of this approach could be an underesti-
mation of TB incidence in our migrant population, par-
ticularly among former asylum seekers. This is because 
asylum seekers apply for asylum at arrival in Denmark 
and there is consequently a delay between arrival and 
receiving residency. The delay differs during the study 
period, but is described as between 6 and 12 months 
in general [39]. Regarding quota refugees and family-
reunited immigrants, they hold a residence permit 
when they arrive in Denmark and there is therefore 
usually no delay between arrival in Denmark and resi-
dency. However, because of the register-based design 
of this study, we do not know the time span between 
arrival in Europe and residency in Denmark. Forth, we 
compare our results to studies from other countries, 
but the migrant population in Denmark may look dif-
ferent from migrant populations in other European 
countries because of differences in policies, traditional 
migration routes, etc.
Conclusion
All migrants had increased TB risk compared with the 
Danish-born population. The risk was particularly high 
for migrants from sub-Saharan Africa, family-reunified 
to refugees, quota refugees and former asylum seek-
ers. Screening programmes mostly focus on asylum 
seekers, but other groups at high risk of TB are missed. 
Thus, awareness of TB in all high-risk groups should be 
strengthened and TB screening programmes should be 
optimised. This study suggests a need for a more com-
prehensive approach, possibly one that incorporates 
Table 5
Incidence rates and incidence rate ratios of tuberculosis casesa among migrants by migrant status and region of originb, 
Denmark, 1993–2015 (n = 142,314)
Migrant status Total Eastern Europe and Central Asia
Middle East and North 
Africa South-East Asia Sub-Saharan Africa
IR per 100,000 PY (95% CI)
Former asylum seeker 156 (146–167) 46 (39–54) 35 (26–45) 120 (96–151) 790 (732–853)
Quota refugee 192 (161–229) 0 21 (24–71) 325 (254–415) 368 (278–489)
Family-reunified to:
- Danish/Nordics citizens 64 (58–71) 24 (17–36) 21 (12–36) 136 (120–154) 166 (132–209)
- immigrants 71 (57–87) 40 (28–56) 50 (24–106) 179 (131–243) 191 (103–356)
- refugees 199 (179–221) 27 (10–73) 27 (17–42) 137 (106–178) 707 (624–801)
Adjusted IRRc (95% CI)
Former asylum seeker 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Quota refugee 0.81 (0.67–0.98) 0 1.25 (0.68–2.29) 2.56 (1.83–3.57) 0.45 (0.34–0.61)
Family-reunified to:
- Danish/Nordics citizens 0.45 (0.39–0.51) 0.42 (0.28–0.64) 0.57 (0.31–1.05) 1.20 (0.91–1.55) 0.22 (0.17–0.28)
- immigrants 0.64 (0.51–0.80) 0.65 (0.44–0.95) 1.39 (0.63–3.07) 1.44 (0.98–2.11) 0.28 (0.15–0.53)
- refugees 0.90 (0.79–1.03) 0.53 (0.19–1.42) 0.80 (0.46–1.37) 1.17 (0.83–1.67) 0.95 (0.82–1.11)
CI: confidence interval; IR: incidence rate; IRR: incidence rate ratio; PY: person-years; ref: reference group for comparison.
a All cases of tuberculosis: all active tuberculosis cases, including both pulmonary and extrapulmonary tuberculosis.
b The regions of Latin America and the Caribbean, and Europe, North America and Oceania were not included in the analysis because of 
insufficient power.
c Adjusted for age, sex and region of origin.
Bold indicates p < 0.05.
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TB screening into a general health evaluation to 
improve migrant health.
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